Healthpeak Properties (NYSE:DOC) Given New $19.00 Price Target at Robert W. Baird

Healthpeak Properties (NYSE:DOC) had its price objective trimmed by Robert W. Baird from $20.00 to $19.00 in a research report released on Monday morning,Benzinga reports. The firm currently has an outperform rating on the real estate investment trust’s stock.

A number of other research analysts also recently weighed in on DOC. Evercore decreased their price objective on shares of Healthpeak Properties from $21.00 to $19.00 and set an “outperform” rating for the company in a research report on Wednesday, February 4th. Weiss Ratings upgraded shares of Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, January 26th. Jefferies Financial Group downgraded shares of Healthpeak Properties from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $21.00 to $17.00 in a research report on Monday, December 15th. Wall Street Zen downgraded shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Saturday, March 28th. Finally, The Goldman Sachs Group started coverage on shares of Healthpeak Properties in a research report on Friday, January 9th. They issued a “neutral” rating and a $17.00 price objective for the company. Six equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $19.19.

Healthpeak Properties Trading Up 0.9%

Shares of Healthpeak Properties stock opened at $16.68 on Monday. The firm has a 50-day simple moving average of $17.05 and a two-hundred day simple moving average of $17.43. The company has a market cap of $11.59 billion, a P/E ratio of 166.77, a price-to-earnings-growth ratio of 8.84 and a beta of 1.10. Healthpeak Properties has a fifty-two week low of $15.71 and a fifty-two week high of $19.68. The company has a debt-to-equity ratio of 1.21, a quick ratio of 2.82 and a current ratio of 2.82.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share for the quarter, topping analysts’ consensus estimates of $0.45 by $0.02. The business had revenue of $719.40 million during the quarter, compared to the consensus estimate of $685.14 million. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. The company’s revenue was up 3.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. As a group, equities analysts predict that Healthpeak Properties will post 1.86 earnings per share for the current fiscal year.

Institutional Trading of Healthpeak Properties

A number of institutional investors and hedge funds have recently modified their holdings of DOC. Norges Bank purchased a new stake in shares of Healthpeak Properties during the fourth quarter worth about $153,550,000. JPMorgan Chase & Co. increased its stake in shares of Healthpeak Properties by 41.0% during the third quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock worth $540,730,000 after purchasing an additional 8,212,504 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Healthpeak Properties by 694.6% during the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock worth $153,520,000 after purchasing an additional 7,007,777 shares in the last quarter. Fuller & Thaler Asset Management Inc. increased its stake in shares of Healthpeak Properties by 19.2% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock worth $476,744,000 after purchasing an additional 4,776,056 shares in the last quarter. Finally, Equity Investment Corp increased its stake in shares of Healthpeak Properties by 209.6% during the third quarter. Equity Investment Corp now owns 5,330,948 shares of the real estate investment trust’s stock worth $102,088,000 after purchasing an additional 3,608,849 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.